Growth differentiation factor 15 in pregnant women: A hero or villain? DOI Creative Commons

Yiu‐Tai Li,

Wei‐Ting Chao, Peng‐Hui Wang

et al.

Taiwanese Journal of Obstetrics and Gynecology, Journal Year: 2021, Volume and Issue: 60(4), P. 593 - 594

Published: July 1, 2021

Language: Английский

Endometrial cancer: Part I. Basic concept DOI
Peng‐Hui Wang,

Szu‐Ting Yang,

Chia-Hao Liu

et al.

Taiwanese Journal of Obstetrics and Gynecology, Journal Year: 2022, Volume and Issue: 61(6), P. 951 - 959

Published: Nov. 1, 2022

Language: Английский

Citations

46

An update of polycystic ovary syndrome: causes and therapeutics options DOI
Abeer M. Rababa’h,

Bayan R. Matani,

Alaa Yehya

et al.

Heliyon, Journal Year: 2022, Volume and Issue: 8(10), P. e11010 - e11010

Published: Oct. 1, 2022

Language: Английский

Citations

40

Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage DOI Creative Commons

Yican Guo,

Liru Xue,

Weicheng Tang

et al.

Human Reproduction Update, Journal Year: 2024, Volume and Issue: 30(5), P. 614 - 647

Published: June 28, 2024

Chemotherapy-associated ovarian damage (CAOD) is one of the most feared short- and long-term side effects anticancer treatment in premenopausal women. Accumulating detailed data show that different chemotherapy regimens can lead to disturbance hormone levels, reduced or lost fertility, an increased risk early menopause. Previous studies have often focused on direct chemotherapeutic drugs follicles, such as DNA damage-mediated apoptotic death primordial follicle burnout. Emerging evidence has revealed imbalance microenvironment during chemotherapy. The provides nutritional support transportation signals stimulate growth development ovulation, corpus luteum formation. close interaction between follicles determine function. Therefore, designing novel precise strategies manipulate may be a new strategy protect function

Language: Английский

Citations

17

Androgen Excess Induced Mitochondrial Abnormality in Ovarian Granulosa Cells in a Rat Model of Polycystic Ovary Syndrome DOI Creative Commons

Linyi Song,

Jin Yu, Danying Zhang

et al.

Frontiers in Endocrinology, Journal Year: 2022, Volume and Issue: 13

Published: March 17, 2022

Androgen excess could profoundly lead to follicular dysplasia or atresia, and finally result in polycystic ovary syndrome (PCOS); however, the exact mechanism remains be fully elucidated.PCOS model rats were induced by dehydroepiandrosterone, their fertility was assessed. The ovarian granulosa cells (GCs) from matured follicles of PCOS collected identified immunofluorescence. mitochondrial ultrastructure observed transmission electron microscope function determined detecting adenosine triphosphate (ATP) content mtDNA copy number. Besides, expressions respiratory chain complexes ATP synthases relation analyzed.The successfully induced, reproductive outcomes obviously adverse. GCs layer apparently cut down distinctly destroyed. number greatly reduced, NDUFB8 ATP5j significantly down-regulated without obvious deletion 4834-bp.Androgen damage rat down-regulating expression PCOS.

Language: Английский

Citations

27

Association between Pre-Pregnancy Overweightness/Obesity and Pregnancy Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis DOI Open Access

Szu‐Ting Yang,

Chia-Hao Liu, Sheng‐Hsiang Ma

et al.

International Journal of Environmental Research and Public Health, Journal Year: 2022, Volume and Issue: 19(15), P. 9094 - 9094

Published: July 26, 2022

Polycystic ovary syndrome (PCOS) is a common metabolic problem in women of reproductive age. Evidence suggests pregnant with PCOS may have higher risk the development adverse pregnancy outcomes; however, relationship between pre-pregnancy overweight/obesity and outcomes remains uncertain. We try to clarify subsequent outcomes. Therefore, we conducted this systematic review meta-analysis. used databases obtained from PubMed, Embase, Web Science, Cochrane databases, plus hand-searching, examine association overweightness/obesity inception 4 February 2022. A total 16 cohort studies, including 14 retrospective studies (n = 10,496) another two prospective 818), contributed 11,314 for analysis. The meta-analysis showed significantly increased odds miscarriage rate whose body mass index (BMI) above overweight (OR 1.71 [95% CI 1.38-2.11]) or obese 2.00 1.38-2.90]) under random effect model. tests subgroup difference indicated was consistent, regardless which cut-off (24 25 kg/m2) obesity (28 30 used. With same strategies, found that control group live birth compared those as well 0.79 0.71-0.89], OR 0.78 0.67-0.91]). By contrast, did not find any preterm birth. Based on aforementioned findings, main critical factor contributing worse outcome be an early fetal loss these overweight/obesity. Since were associated outcomes, supposed weight reduction before attempting improve

Language: Английский

Citations

25

To do one and to get more: Part I. Diabetes and bone DOI Creative Commons

Wen-Ling Lee,

Peng‐Hui Wang,

Szu‐Ting Yang

et al.

Journal of the Chinese Medical Association, Journal Year: 2022, Volume and Issue: 85(10), P. 965 - 971

Published: Sept. 6, 2022

Type 2 diabetes mellitus (T2DM), is a chronic metabolic disease, characterized by the presence of hyperglycemia and insulin resistance. The key treatment strategies for T2DM include modification lifestyle, medications, continuous glucose monitoring. DM patients often have DM-associated morbidities comorbidities; however, disorders musculoskeletal system are neglected, compared to other major systems in patients. Based on sharing similar pathophysiology osteoporosis, it supposed that use antidiabetic agents (ADAs) may not only provide lowering level effect maintenance sugar homeostasis directly delay tissue damage secondary but also offer benefits, such as prevention developing osteoporosis fractures. current review, evidence shows positive correlation between or fracture, effectiveness using ADA subsequent reduction fracture seems be inconclusive. Although benefits bone health uncertain, potential value “To do one get more” therapeutic strategy should always persuaded. At least, an establishment healthy lifestyle work, because improves status resistance subsequently helps control, prevents DM-related micro- macrovascular injury, possibly strengthens general performance system. With stronger support, risk “fall” decreased, associated with fracture. available market does satisfy policy yet, we looking forward seeing continuously advanced technology drug development diabetic hope see their extra-sugar–lowering effects.

Language: Английский

Citations

21

The impact of COVID-19 in pregnancy: Part I. Clinical presentations and untoward outcomes of pregnant women with COVID-19 DOI Creative Commons
Peng‐Hui Wang,

Wen-Ling Lee,

Szu‐Ting Yang

et al.

Journal of the Chinese Medical Association, Journal Year: 2021, Volume and Issue: 84(9), P. 813 - 820

Published: Aug. 5, 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019, COVID-19) is a pandemic with rapidly and widely disseminating to the world. Based on experiences about H1N1, Acute Respiratory Syndrome (SARS) Middle East (MERS) pandemics, pregnant women who are infected disproportionately more likely develop severe illness need hospitalizations, intensive care, finally die of diseases compared those nonpregnant counterparts or without infection. Although than one half COVID-19 asymptomatic, as well their symptoms frequently mild, this observation presents further challenge regarding service provision, prevention, management, in which may result overlooking risk during pregnancy. As predictable, despite much advance critical care recent decades, 2020 pandemic, really at higher progress illness; require hospitalization; such use mechanical ventilation extracorporeal membrane oxygenation (ECMO), most important, COVID-19. The magnitude extend newborn from resultant significantly increasing perinatal neonatal morbidity mortality rates. heightened untoward outcomes emphasizes an urgent national international recommendations guidelines optimize prevention management strategies for Active passive approved effective attempt be Understanding that vulnerable population essential improve novel pandemic. current review part I summarize up-to-date information impact laboratory-confirmed SARS-CoV-2 infection focus clinical presentations pregnancy these SARS-CoV-2.

Language: Английский

Citations

27

New insights on mitochondrial heteroplasmy observed in ovarian diseases DOI Creative Commons
Yong Zhou, Yang Jin, Tianyu Wu

et al.

Journal of Advanced Research, Journal Year: 2023, Volume and Issue: 65, P. 211 - 226

Published: Dec. 6, 2023

The reportedly high mutation rate of mitochondrial DNA (mtDNA) may be attributed to the absence histone protection and complete repair mechanisms. Mitochondrial heteroplasmy refers coexistence wild-type mutant mtDNA. Most healthy individuals carry a low point load (<1%) in their mtDNA, typically without any discernible phenotypic effects. However, as it exceeds certain threshold, cause onset various diseases. Since ovary is highly energy-intensive organ, relies heavily on function. can potentially contribute variety significant ovarian disorders. Review: In this review, we have elucidated close relationship between mtDNA diseases, summarized novel avenues strategies for potential treatment these Key Scientific Concepts disorders, including polycystic syndrome, premature insufficiency, endometriosis. Current related are untargeted bioavailability. Nanoparticle delivery systems loaded with modulators, replacement/transplantation therapy, mitochondria-targeted gene editing therapy offer promising paths towards more effective treatments despite ongoing challenges.

Language: Английский

Citations

11

Interface between reproductive and metabolic dysfunction in polycystic ovary syndrome DOI
Melody A. Rasouli,

Jessica Katz,

Daniel A. Dumesic

et al.

Current Opinion in Obstetrics & Gynecology, Journal Year: 2025, Volume and Issue: unknown

Published: April 29, 2025

Purpose of review New concepts have emerged regarding how interrelationships hyperandrogenism and hyperinsulinemia from systemic insulin resistance contribute to the origins polycystic ovary syndrome (PCOS). Although these androgen-insulin are associated with several reproductive metabolic variables, their specific cause effect relationships remain unclear. This examines causal between understand complex interactions phenotypic expression PCOS. Recent findings Clinical interventions for treatments as well in-vitro studies androgen actions on critical target tissues examined why central Summary Bidirectional in normal-weight PCOS women may originally evolved an ancient adaptation simultaneously favor fat storage energy utilization survival reproduction during famine. These now predispose diseases pregnancy complications today’s obesogenic environment and, therefore, require improved preventive healthcare optimize long-term health children.

Language: Английский

Citations

0

The effects of first-line pharmacological treatments for reproductive outcomes in infertile women with PCOS: a systematic review and network meta-analysis DOI Creative Commons

Ge Peng,

Zhe Yan, Yuqi Liu

et al.

Reproductive Biology and Endocrinology, Journal Year: 2023, Volume and Issue: 21(1)

Published: March 3, 2023

Abstract Background Polycystic ovarian syndrome (PCOS) is one of the most common causes infertility in reproductive-age women. However, efficacy and optimal therapeutic strategy for reproductive outcomes are still under debate. We conducted a systematic review network meta-analysis to compare different first-line pharmacological therapies terms women with PCOS infertility. Methods A retrieval databases was conducted, randomized clinical trials (RCTs) interventions infertile were included. The primary pregnancy live birth, secondary miscarriage, ectopic multiple pregnancy. based on Bayesian model performed effects strategies. Results total 27 RCTs 12 included, all tended increase pregnancy, especially pioglitazone (PIO) (log OR 3.14, 95% CI 1.56 ~ 4.70, moderate confidence), clomiphene citrate (CC) + exenatide (EXE) (2.96, 1.07 4.82, confidence) CC metformin (MET) PIO (2.82, 0.99 4.60, confidence). Moreover, MET (2.8, -0.25 6.06, very low could birth when compared placebo, even without significant difference. For outcomes, showed tendency miscarriage (1.44, -1.69 5.28, (-11.25, -33.7 0.57, LZ (-10.44, -59.56 42.11, beneficial decreasing (0.07, -4.26 4.34, neutral effect Subgroup analysis demonstrated no difference between these medications placebo obese participants. Conclusions Most treatments effective improving should be recommended as improve outcomes. none above had PCOS. Trial registration CRD42020183541; 05 July 2020

Language: Английский

Citations

9